Survival and the prognosticators of peritoneal cytology-positive pancreatic cancer patients undergoing curative resection followed by adjuvant chemotherapy
Author(s) -
Toru Aoyama,
Yosuke Atsumi,
Keisuke Kazama,
Masaaki Murakawa,
Manabu Shiozawa,
Satoshi Kobayashi,
Makoto Ueno,
Manabu Morimoto,
Norio Yukawa,
Takashi Oshima,
Takaki Yoshikawa,
Yasushi Rino,
Munetaka Masuda,
Soichiro Morinaga
Publication year - 2018
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.194927
Subject(s) - medicine , lymph , pancreatic cancer , lymph node , oncology , chemotherapy , univariate analysis , survival rate , adjuvant , gastroenterology , cancer , surgery , multivariate analysis , pathology
The factors associated with the survival and prognosis of peritoneal cytology (CY)-positive pancreatic cancer patients who undergo curative resection followed by adjuvant chemotherapy have not been established.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom